JAG Team Insights — Getting (Re) Familiar with Discount Bonds

Bloomberg US Aggregate Index: Average Price

November 15, 2023 Summary Rising interest rates have led to steep price declines in bond markets. Some bonds trade at deep price discounts even though their issuer’s credit quality remains strong. Bonds purchased at a market discount may offer a unique tax-deferral opportunity for investors. Read more…

JAG Team Insights — Fixing Your Fixed Income Allocation: Back to Basics

Chart showing Fed Funds Target Rate During Hiking Cycles 1986 - 2023

September 30, 2023 Capital markets have been put through the wringer since the Fed started their rake hike cycle, resulting in many fixed income portfolios failing to achieve their stabilizing role in investors’ asset allocations. The Fed, by its own admission, was late recognizing the severity and persistence of inflation. Behind the curve, but determined […]

3rd Quarter 2023: Rising Rates Create Opportunities…And Risks

Cartoon showing a man and woman sitting in front of a bank loan officer.

Market Overview Stocks had a strong start to the third quarter before pulling back in August and September. Overall, the S&P 500 ended the quarter with modest losses, in part attributable to another spike higher in interest rates. In our opinion, the resilience in the US economy could be contributing to the recent market volatility. […]

2nd Quarter 2023: The Return of Guarded Optimism

Cartoon showing a man with a smiley face and the headline "The Return of Guarded Optimism

Market Overview Last quarter began with markets still in the throes of the regional bank crisis following the March failures of Silicon Valley Bank and Signature Bank, which was followed on May 1st by the failure of First Republic Bank. Although investors feared a broader contagion in the regional banking industry, the Federal Deposit Insurance […]

JAG Team Insights — Obesity Drug Craze Approaching Critical Milestone

Graphic chart showing disrupting disease progression in diabetes and obesity to improve outcomes

June 2023 In recent years, a class of drugs known as GLP-1 agonists have experienced an unprecedented rise in popularity and captured the attention of doctors, patients, and investors alike. GLP-1 is short for glucagon-like peptide 1, a natural hormone produced by the human body which the drugs are designed to mimic. For the general […]

1st Quarter 2023: Markets Show Resilience to Start 2023

A man and woman each holding laptops and suitcases cartoon with the caption "I'm Leaving You for the Bing Chatbot"

Markets Show Resilience to Start 2023! The S&P 500 kicked off 2023 with a first quarter total return of 7.5%. Bonds also delivered mostly positive returns last quarter, as interest rates declined, and credit spreads remained relatively tight. It appears investors are expressing optimism that moderating inflation, combined with “better than feared” corporate earnings results, […]

JAG Team Insights — The AI Revolution: Framing Risks and Opportunities

April 4, 2023 Over the past several months, Artificial Intelligence (AI) has leaped from the realm of science fiction into reality right before our eyes. The evolution has taken decades, but the impressive growth in power and user access has accelerated very recently with ChatGPT. This process continues to evolve extremely rapidly, in raw technology, […]

JAG Team Insights — The Debt Ceiling Debate & Financial Market Impacts

February 17, 2023 Raising the debt ceiling is a regular feature of the US political and financial landscape. Since June 1942 the Federal borrowing limit has been raised or suspended a total of 93 times. The US government hit the statutory debt ceiling on January 19, 2023, which has prompted debate over what will ultimately […]

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

eMoney

eMoney is an industry-leading financial planning platform designed to help advisors, planners, and RIAs deliver personalized, comprehensive financial advice to clients across all stages of life.

Nitrogen

Nitrogen is a client-engagement and advisor platform built to bring clarity, quantification, and alignment to risk tolerance and portfolio construction. It uses a proprietary system that simplifies risk into a single, objective metric — the Risk Number® — allowing advisors and clients to speak the same language about risk, rather than relying on vague, subjective labels like “moderate” or “aggressive.”

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

You are now leaving

www.jagcap.com